25.18 USD
↗ 1.05 (4.35%)AT CLOSE (11:59 AM EDT)
Evommune, Inc.
EVMNNYSE • USD
25.09
↘ 0.09 (0.36%)
POST MARKET (AS OF 08:15 PM EDT)
Post Market
AS OF 08:15 PM EDT
25.09
↘ 0.09 (0.36%)
Market: CLOSED
Evommune, Inc. (EVMN) trades at $25.18 per share. Technical indicators currently signal "Strong Buy". Key drivers include negative Return on Equity and a bullish Golden Cross on the moving averages. EVMN is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Jun 26, 2026.
Open?$23.85
High?$25.87
Low?$23.85
Prev. Close?$24.13
Volume?1.4M
Avg. Volume?513.1K
VWAP?$24.71
Rel. Volume?2.73x
Bid / Ask
Bid?$19.60 × 100
Ask?$25.42 × 100
Spread?$5.82
Midpoint?$22.51
Valuation & Ratios
Market Cap?906.9M
Shares Out?36.0M
Float?10.0M
Float %?31.9%
P/E Ratio?N/A
P/B Ratio?2.98
EPS?-$2.14
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
Employees
48
Market Cap
869.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-11-06
Address
1891 PAGE MILL RD
PALO ALTO, CA
Phone: (650) 223-7745
PALO ALTO, CA
Phone: (650) 223-7745
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestSqueeze Risk
Short % of Float?42.48%Squeeze Risk
Short Interest?4.3M
Days to Cover?9.5
Free Float10.0M
Avg Daily Volume451.7K
Settlement Date2026-06-15
Financial Health
Current Ratio?20.36Strong
Quick Ratio?20.36Strong
Cash Ratio?4.56Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?2.98CHEAP▾
Peers100
S&P56
P/S?69.76HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-10.6CHEAP▾
S&P97
EV/Sales?66.09HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-25.3%WEAK▾
S&P7
ROA?-23.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$859.2M
Fundamentals ratios updated end of day